Часть 6. Инфекционный эндокардит во время беременности
Вызовом для врача в период беременности у кардиологического пациента являются изменения сердечно-сосудистой физиологии, которые могут имитировать болезнь сердца и путать клиническую картину [380, 381].
Заболеваемость ИЭ во время беременности, как сообщается, составляет 0,006% [382]. Следовательно, ИЭ во время беременности встречается крайне редко, и является либо осложнением уже существующего сердечного поражения, либо следствием ВВП. Материнская смертность достигает 33%, большинство случаев смерти связаны с СН или эмболическим событием, а внутриутробная смертность составляет 29% [382]. Пристальное внимание должно быть уделено любой беременной женщине с неясной лихорадкой и сердечным шумом. Быстрое выявление ИЭ и соответствующее лечение играют важную роль в снижении риска материнской и внутриутробной смертности [382].
66
Н. Литература
1. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139-149.
2. Habib G. Management of infective endocarditis. Heart 2006;92:124-130.
3. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G,
von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers
J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA,
Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P.
Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the
task force on infective endocarditis of the European society of cardiology. Eur Heart J
2004;25:267-276.
4. Naber CK, Erbel R, Baddour LM, Horstkotte D. New guidelines for infective endocarditis:
a call for collaborative research. Int J Antimicrob Agents 2007;29: 615-616.
5. Moulds RF, Jeyasingham MS. Antibiotic prophylaxis against infective endocarditis: time
to rethink. MedJ Aust2008;189:301-302.
|
|
|
6. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger
A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M,
Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferried P, Gardner T, Goff D,
Durack DT. Prevention of infective endocarditis: guidelines from the American Heart
Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and
Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council
on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of
Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;l 16:1736-1754.
7. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME,
Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS,
Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA.
Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a
statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and
Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical
Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association:
endorsed by the Infectious Diseases Society of America. Circulation 2005;l 11 :e394-e434.
8. Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O'Gara PT,
O'Rourke RA, Shah PM. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused
Update on Infective Endocarditis. A Report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines. Circulation 2008;l 18:887-896.
9. Danchin N, Duval X, Leport С Prophylaxis of infective endocarditis: French
recommendations 2002. Heart 2005;91:715-718.
10. Gould FK, Elliott TS, Foweraker J, Fulford M, Perry JD, Roberts GJ, Sandoe JA,
Watkin RW, Working Party of the British Society for Antimicrobial С Guidelines for the
prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial
Chemotherapy. J Antimicrob Chemother 2006; 57:1035-1042.
|
|
|
11. Naber CK, Al-Nawas B, Baumgartner B, Becker HJ, Block M, Erbel R, Ertl G,
Flu'ckiger U, Franzen D, Gohlke-Ba'rwolf C, Gattringer R, Graninger R, Handrick W,
Herrmann M, Heying R, Horstkotte D, Jaussi A, Kern P, Kramer HH, Ku'hl S, Lepper PM,
Leyh RG, Lode H, Mehlhorn U, Moreillon P, Mu'gge A, Mutters R, Niebel J, Peters G, Rosenhek
R, Schmaltz AA, Seifert H, Shah PM, Sitter H, Wagner W, Wahl G, Werdan K, Zuber M.
Prophylaxe derinfektio'sen Endokarditis. Kardiologe2007; 1:243-250.
12. Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of
NICE guidance. BMJ 2008;336:770-771.
13. Bonow RO, Carabello В A, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch
WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS.
2008 focused update incorporated into the ACC/ AHA 2006 guidelines for the management
67
of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:el-el42.
14. Hoen B, Alia F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP,
Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R,
Vandenesch F. Changing profile of infective endocarditis: results of a 1-year survey in France.
JAMA2002;288:75-81.
15. Hill ЕЕ, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE.
Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective
cohort study. Eur Heart J 2007;28:196-203.
16. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM,
Wilson WR, Baddour LM. A systematic review of population-based studies of infective
endocarditis. Chest 2007;132:1025-1035.
17. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark
C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated
bloodstream infections in adults: a reason to change the accepted definition of community-
acquired infections. Ann Intern Med 2002; 137:791-797.
|
|
|
18. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM,
Mirzoyev Z, Moustafa SE, Hoskin TL, Mandrekar JN, Wilson WR, Baddour LM. Temporal trends
in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA
2005;293:3022-3028.
19. Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Chaabane ТВ, Jemaa MB, Boujnah
R, Chakroun M, Daoud M, Gaha R, Kafsi N, Khalfallah A, Slimane L, Zaouali M. Epidemiology of
infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis
2007; 11:230-233.
20. Nkomo VT. Epidemiology and prevention of valvular heart diseases and infective
endocarditis in Africa. Heart 2007;93:1510-1519.
21.Cabell CH Jr., Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-94.
22. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR,
Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan
E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS. Staphylococcus aureus endocarditis:
a consequence of medical progress. JAMA2005;293:3012-3021.
23. Ribera E, Miro JM, Cortes E, Cruceta A, Merce J, Marco F, Planes A, Pare JC, Moreno A,
Ocana I, Gatell JM, Pahissa A. Influence of human immunodeficiency virus 1 infection and degree
of immunosuppression in the clinical characteristics and outcome of infective endocarditis in
intravenous drug users. Arch Intern Med 1998;158:2043-2050.
24. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of
infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore)
1995;74:324-339.
25. Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM,
Feldman RS, Kaye D. Incidence of infective endocarditis in the Delaware Valley, 1988-1990.
Am J Cardiol 1995;76:933-936.
|
|
|
26. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial
endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med 1992;152:1863-1868.
27. Aksoy O, Meyer LT, Cabell CH, Kourany WM, Pappas PA, Sexton DJ. Gender
differences in infective endocarditis: pre- and co-morbid conditions lead to different
management and outcomes in female patients. Scand J Infect Dis2007;39:101-107.
68
28. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, Karchmer
AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falco V, Holland DJ,
Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell
CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the
International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:
463-473.
29. Chu VH Jr., Cabell CH, Abrutyn E, Corey GR, Hoen B, Miro JM, Olaison L, Stryjewski
ME, Pappas P, Anstrom KJ, Eykyn S, Habib G, Benito N, Fowler VG Jr. Native valve
endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the
International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004;39:1527-1530.
30. Chu VH Jr., Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan
E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon
DL, Utili R, Delahaye F, Corey GR, Fowler VG Jr. Emergence of coagulase-negative staphylococci
as a cause of native valve endocarditis. Clin Infect Dis 2008;46:232-242.
31. Revilla A, San Roman JA, Lopez J, Vilacosta I, Luaces M, Fernandez-Aviles F.
Current profile of left-sided native valve endocarditis caused by coagulasenegative
Staphylococcus. RevEsp Cardiol 2005;58:749-752.
32. Richardson DC, Burrows LL, Korithoski B, Salit Ш, Butany J, David ТЕ, Conly JM.
Tropheryma whippelii as a cause of afebrile culture-negative endocarditis: the evolving spectrum of
Whipple's disease. J Infect 2003;47:170-173.
33. Croft LB, Donnino R, Shapiro R, Indes J, Fayngersh A, Squire A, Goldman ME. Age-
related prevalence of cardiac valvular abnormalities warranting infectious endocarditis prophylaxis.
Am J Cardiol 2004;94:386-389.
34. Que YA, Haefliger JA, Piroth L, Francois P, Widmer E, Entenza JM, Sinha B,
Herrmann M, Francioli P, Vaudaux P, Moreillon P. Fibrinogen and fibronectin binding cooperate
for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp
Med2005;201:1627-1635.
35. Moreillon P, Overholser CD, Malinverni R, Bille J, Glauser MP. Predictors of
endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal
disease. J Infect Dis 1988;157:990-995.
36. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME,
Korzeniowski OM, Kaye D. Dental and cardiac risk factors for infective endocarditis. A
population-based, case-control study. Ann Intern Med 1998;129: 761-769.
37. Moreillon P, Que YA, Bayer AS. Pathogenesis of streptococcal and staphylococcal
endocarditis. Infect Dis Clin North Am 2002;16:297-318.
38. Fowler VG Jr, Mclntyre LM, Yeaman MR, Peterson GE, Barth Reller L, Corey GR, Wray
D, Bayer AS. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of
Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J
Infect Dis 2000;182:1251-1254.
39. Okell CC, Elliott SD. Bacteraemia and oral sepsis: with special reference to the aetiology
of subacute endocarditis. Lancet 1935;226:869-872.
40. Glauser MP, Bernard JP, Moreillon P, Francioli P. Successful single-dose amoxicillin
prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of
protection. J Infect Dis 1983; 147:568-575.
41. Lockhart PB. The risk for endocarditis in dental practice. Periodontology 2000; 23: 127 -
135.
42. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing,
tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol
2006;33:401-407.
43. Roberts GJ. Dentists are innocent! 'Everyday' bacteremia is the real culprit: a review and
assessment of the evidence that dental surgical procedures are a principal cause of bacterial
endocarditis in children. Pediatr Cardiol 1999;20: 317-325.
69
44. Duval X, Leport С. Prophylaxis of infective endocarditis: current tendencies, continuing
controversies. Lancet Infect Dis 2008;8:225-232.
45. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North
Am 1993;7:9-19.
46. Pallasch TJ. Antibiotic prophylaxis: problems in paradise. Dent Clin North Am
2003;47:665-679.
47. Duval X, Alia F, Hoen B, Danielou F, Larrieu S, Delahaye F, Leport C, Briancon S.
Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing
dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 2006;42:el02-el07.
48. Shanson D. New British and American guidelines for the antibiotic prophylaxis of
infective endocarditis: do the changes make sense? A critical review. Curr Opin Infect Dis
2008;21:191-199.
49. Hall G, Hedstrom SA, Heimdahl A, Nord CE. Prophylactic administration of
penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect
Disl993;17:188-194.
50. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK.
Bacteremia associated with toothbrushing and dental extraction. Circulation 2008; 117:3118-
3125.
51. Lacassin F, Hoen B, Leport C, Selton-Suty C, Delahaye F, Goulet V, Etienne J, Briancon
S. Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J
1995;16:1968-1974.
52. Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel
MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet
1992;339:135-139.
53. Oliver R, Roberts GJ, Hooper L. Penicillins for the prophylaxis of bacterial endocarditis
in dentistry. Cochrane Database Syst Rev 2004:CD003813.
54. Anderson DJ, Olaison L, McDonald JR, Miro JM, Hoen B, Selton-Suty C, Doco-
Lecompte T, Abrutyn E, Habib G, Eykyn S, Pappas PA, Fowler VG, Sexton DJ, Almela M,
Corey GR, Cabell CH. Enterococcal prosthetic valve infective endocarditis: report of 45 episodes
from the International Collaboration on Endocarditis-merged database. Eur J Clin Microbiol Infect
Dis2005;24:665-670.
55. Lalani T Jr., Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, Woods CW, Cabell
CH, Hoen B, Selton-Suty C, Doco-Lecompte T, Chirouze C, Raoult D, Miro JM, Mestres С A,
Olaison L, Eykyn S, Abrutyn E, Fowler VG Jr. Prosthetic valve endocarditis due to coagulase-
negative staphylococci: findings from the International Collaboration on Endocarditis Merged
Database. Eur J Clin Microbiol Infect Dis 2006;25:365-368.
56. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, Singh RK, Fowler VG Jr, Corey
GR, Aksoy O, Woods CW. Repeat infective endocarditis: differentiating relapse from reinfection.
Clin Infect Dis 2005;41:406-409.
57. Renzulli A, Carozza A, Romano G, De Feo M, Delia Corte A, Gregorio R,
Cotrufo M. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann
Thorac Surg 2001;72:39-43.
58. Li W, Somerville J. Infective endocarditis in the grown-up congenital heart
(GUCH) population. Eur Heart J 1998; 19:166-173.
59. Takeda S, Nakanishi T, Nakazawa M. A 28-year trend of infective endocarditis associated
with congenital heart diseases: a single institute experience. Pediatr Int 2005;47:392-396.
60. Sherman-Weber S, Axelrod P, Suh B, Rubin S, Beltramo D, Manacchio J,
Furukawa S, Weber T, Eisen H, Samuel R. Infective endocarditis following orthotopic heart
transplantation: 10 cases and a review of the literature. Transpl Infect Dis 2004;6:165-170.
61. Millar ВС, Moore JE. Antibiotic prophylaxis, body piercing and infective endocarditis. J
Antimicrob Chemother 2004;53:123-126.
62. Yoshinaga M, Niwa K, Niwa A, Ishiwada N, Takahashi H, Echigo S, Nakazawa M. Risk
70
factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol 2008;101:114-118.
63. Thilen U. Infective endocarditis in adults with congenital heart disease. Curr Infect Dis
Rep2003;5:300-306.
64. Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A,
Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective
endocarditis. Clin Infect Dis 2008;47:1287-1297.
65. Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ.
Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of
infectious disease consultants and review. Clin Infect Dis 2002;34: 1621-1626.
66. Martin MV, Longman LP, Forde MP, Butterworth ML. Infective endocarditis and
dentistry: the legal basis for an association. Br Dent J 2007;203:El; discussion 38-39.
67. Prendergast BD. The changing face of infective endocarditis. Heart 2006;92: 879-
885.
68. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, Casalta JP,
Gouvernet J, Derumeaux G, Iarussi D, Ambrosi P, Calabro R, Riberi A, Collart F, Metras D, Lepidi
H, Raoult D, Harle JR, Weiller PJ, Cohen A, Habib G. Risk of embolism and death in infective
endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation
2005;112:69-75.
69. Perez de Isla L, Zamorano J, Lennie V, Vazquez J, Ribera JM, Macaya C. Negative blood
culture infective endocarditis in the elderly: long-term follow-up. Gerontology 2007;53:245-249.
70. Sachdev M, Peterson GE, Jollis JG. Imaging techniques for diagnosis of infective
endocarditis. Infect Dis Clin North Am 2002;16:319-337, ix.
71. Greaves К, Мои D, Patel A, Celermajer DS. Clinical criteria and the appropriate use of
transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003;89:273-275.
72. Petti CA Jr., Fowler VG Jr. Staphylococcus aureus bacteremia and endocarditis. Cardiol
Clin 2003;21:219-233,vii.
73. Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart
2004;90:614-617.
74. Hill ЕЕ, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC.
Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-
year study. Am Heart J 2007; 154:923-928.
75. Vieira ML, Grinberg M, Pomerantzeff PM, Andrade JL, Mansur AJ. Repeated
echocardiographic examinations of patients with suspected infective endocarditis. Heart
2004;90:1020-1024.
76. Chirillo F, Pedrocco A, De Leo A, Bruni A, Totis O, Meneghetti P, Stritoni P. Impact of
harmonic imaging on transthoracic echocardiographic identification of infective endocarditis and its
complications. Heart 2005;91:329-333.
77. Feuchtner GM, Stolzmann P, Dichtl W, Schertler T, Bonatti J, Scheffel H, Mueller
S, Plass A, Mueller L, Bartel T, Wolf F, Alkadhi H. Multislice computed tomography in infective
endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am
Coll Cardiol 2009;53:436-444.
78. Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, Branger S, Gouriet F,
Imbert G, Bothello E, Collart F, Habib G. Contribution of systematic serological testing in
diagnosis of infective endocarditis. J Clin Microbiol 2005;43:5238-5242.
79. Tornos P, lung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf C,
Butchart EG, Ravaud P, Vahanian A. Infective endocarditis in Europe: lessons from the Euro heart
survey. Heart 2005;91:571-575.
80. Delahaye F, Rial MO, de Gevigney G, Ecochard R, Delaye J. A critical appraisal of the
quality of the management of infective endocarditis. J Am Coll Cardiol 1999; 33:788-793.
81. Baron EJ, Scott JD, Tompkins LS. Prolonged incubation and extensive subculturing do
not increase recovery of clinically significant microorganisms from standard automated blood
71
cultures. Clin Infect Dis 2005;41:1677-1680.
82. Lamas CC, Eykyn SI. Blood culture negative endocarditis: analysis of 63 cases presenting
over 25 years. Heart 2003;89:258-262.
83. Brouqui P, Raoult D. New insight into the diagnosis of fastidious bacterial endocarditis.
FEMS Immunol Med Mcrobiol 2006;47:l-13.
84. Watkin RW, Lang S, Lambert PA, Littler WA, Elliott TS. The serological diagnosis of
staphylococcal infective endocarditis. J Infect 2006;53:301-307.
85. Millar ВС, Moore IE. Current trends in the molecular diagnosis of infective endocarditis.
Eur I Clin Microbiol Infect Dis 2004;23:353-365.
86. Breitkopf C, Hammel D, Scheld HH, Peters G, Becker K. Impact of a molecular approach
to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation
2005;lll:1415-1421.
87. Rovery C, Greub G, Lepidi H, Casalta IP, Habib G, Collart F, Raoult D. PCR detection of
bacteria on cardiac valves of patients with treated bacterial endocarditis. I Clin Microbiol
2005;43:163-167.
88. Branger S, Casalta IP, Habib G, Collard F, Raoult D. Streptococcus pneumonia
endocarditis: persistence of DNA on heart valve material 7 years after infectious episode. I Clin
Microbiol 2003;41:4435-4437.
89. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-
cultivable bacteria. Int I Antimicrob Agents 2007;30 Suppl 1:S7-S15.
90. Fenollar F, Goncalves A, Esterni B, Azza S, Habib G, Borg IP, Raoult D. A serum protein
signature with high diagnostic value in bacterial endocarditis: results from a study based on
surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. I Infect Dis
2006;194:1356-1366.
91. Millar B, Moore I, Mallon P, Xu I, Crowe M, McClurg R, Raoult D, Earle I,
Hone R, Murphy P. Molecular diagnosis of infective endocarditis - a new Duke's criterion.
Scand I Infect Dis 2001;33:673-680.
92. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis:
utilization of specific echocardiographic findings. Duke Endocarditis Service. Am I Med
1994;96:200-209.
93. Fournier PE, Casalta IP, Habib G, Messana T, Raoult D. Modification of the diagnostic
criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever
endocarditis. Am I Med 1996;100:629-633.
94. Li IS, Sexton DI, Mick N, Nettles R, Fowler VG Ir, Ryan T, Bashore T, Corey GR.
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect
Dis2000;30:633-638.
95. Prendergast BD. Diagnostic criteria and problems in infective endocarditis. Heart
2004;90:611-613.
96. San Roman IA, Lopez I, Vilacosta I, Luaces M, Sarria C, Revilla A, Ronderos R,
Stoermann W, Gomez I, Fernandez-Aviles F. Prognostic stratification of patients with left-sided
endocarditis determined at admission. Am I Med 2007; 120:369 el -e7.
97. Chu VH, Cabell CH, Benjamin DK Ir, Kuniholm EF, Fowler VG Ir, Engemann I, Sexton
DI, Corey GR, Wang A. Early predictors of in-hospital death in infective endocarditis. Circulation
2004;109:1745-1749.
98. Hasbun R, Vikram HR, Barakat LA, Buenconsejo I, Quagliarello VI. Complicated left-
sided native valve endocarditis in adults: risk classification for mortality. IAMA 2003; 289: 1933-
1940.
99. Mansur AJ, Grinberg M, Cardoso RH, da Luz PL, Bellotti G, Pileggi F. Determinants of
prognosis in 300 episodes of infective endocarditis. Thorac Cardiovasc Surg 1996;44:2-10.
100. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality
from infective endocarditis: clinical predictors of outcome. Heart 2002;88: 53-60.
101. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler С Infective
72
endocarditis: determinants of long term outcome. Heart 2002;88:61-66.
102. Delahaye F, Alia F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin F,
Selton-Suty C, Vandenesch F, Vernet V, Hoen B. In-hospital mortality of infective endocarditis:
prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007;39:849-857.
103. Duval X, Alia F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL,
Plesiat P, Celard M, Hoen B, Leport C. Diabetes mellitus and infective endocarditis: the insulin
factor in patient morbidity and mortality. Eur Heart J 2007; 28: 59-64.
104. Jassal DS, Neilan TG, Pradhan AD, Lynch KE, Vlahakes G, Agnihotri AK,
Pi card MH. Surgical management of infective endocarditis: early predictors of short-term morbidity
and mortality. Ann Thorac Surg 2006;82:524-529.
105. Castillo JC, Anguita MP, Ramirez A, Siles JR, Torres F, Mesa D, Franco M,
Munoz I, Concha M, Valles F. Long term outcome of infective endocarditis in patients who were
not drug addicts: a 10 year study. Heart 2000;83:525-530.
106. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Pare C, Almirante B, Munoz
P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabe J,
Morris A, Corey GR, Cabell CH. Contemporary clinical profile and outcome of prosthetic
valve endocarditis. JAMA 2007;297: 1354-1361.
107. Revilla A, Lopez J, Vilacosta I, Villacorta E, Rollan MJ, Echevarria JR, Carrascal Y, Di
Stefano S, Fulquet E, Rodriguez E, Fiz L, San Roman JA. Clinical and prognostic profile of
patients with infective endocarditis who need urgent surgery. Eur Heart J2007;28:65-71.
108. Durack DT, Pelletier LL, Petersdorf RG. Chemotherapy of experimental streptococcal
endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive
streptococci. JClin Invest 1974;53:829-833.
109. Wilson WR, Geraci JE, Wilkowske CJ, Washington JA 2nd. Short-term intramuscular
therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans
streptococci. Circulation 1978;57:1158-1161.
109a. Morris AJ, Drinkovic D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: Implications for duration of treatment after surgery. Clin Infect Dis 2005;41:187-194.
110. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Guidelines for the antibiotic
treatment of endocarditis in adults: report of the Working Party of the British Society for
Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54:971-981.
111. Westling K, Aufwerber E, Ekdahl C, Friman G, Gardlund B, Julander I, Olaison L,
Olesund C, Rundstrom H, Snygg-Martin U, Thalme A, Werner M, Hogevik H. Swedish guidelines
for diagnosis and treatment of infective endocarditis. Scand J Infect Dis 2007;39:929-946.
112. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R.
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.
Antimicrob Agents Chemother 1995;39:650-655.
113. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a
single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin
Infect Dis 1995;21:1406-1410.
114. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A. Treatment of streptococcal
endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient
treatment feasibility. JAMA 1992;267:264-267.
115. Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes
W, Drew RH, Durack DT. Ceftriaxone once daily for four weeks compared with ceftriaxone plus
gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible
streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 1998;27:1470-1474.
116. Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul H,
Bouvet A, Pocidalo JJ, Carbon С Evaluation of antibiotic diffusion into cardiac vegetations by
quantitative autoradiography. J Infect Dis 1989;159:938-944.
117. Wilson AP, Gaya H. Treatment of endocarditis with teicoplanin: a retrospective analysis
73
of 104 cases. J Antimicrob Chemother 1996;38:507-521.
118. Venditti M, Tarasi A, Capone A, Galie M, Menichetti F, Martino P, Serra P. Teicoplanin
in the treatment of enterococcal endocarditis: clinical and microbiological study. J Antimicrob
Chemother 1997;40:449-452.
119. Moet GJ, Dowzicky MJ, Jones RN. Tigecycline (GAR-936) activity against
Streptococcus gallolyticus (bovis) and viridans group streptococci. Diagn Microbiol Infect Dis
2007;57:333-336.
120. Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR. Endocarditis
caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin
Infect Dis 2001;33:577-579.
121. Knoll B, Tleyjeh EVI, Steckelberg JM, Wilson WR, Baddour LM. Infective endocarditis
due to penicillin-resistant viridans group streptococci. Clin Infect Dis 2007; 44:1585-1592.
122. Hsu RB, Lin FY. Effect of penicillin resistance on presentation and outcome of
nonenterococcal streptococcal infective endocarditis. Cardiology 2006;105: 234-239.
123. Shelburne SA 3rd, Greenberg SB, Aslam S, Tweardy DJ. Successful ceftriaxone therapy
of endocarditis due to penicillin non-susceptible viridans streptococci. J Infect 2007;54:e99-101.
124. Martinez E, Miro JM, Almirante B, Aguado JM, Fernandez-Viladrich P,
Fernandez-Guerrero ML, Villanueva JL, Dronda F, Moreno-Torrico A, Montejo M,
Llinares P, Gatell JM. Effect of penicillin resistance of Streptococcus pneumoniae on the
presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Clin Infect Dis
2002;35:130-139.
125. Friedland IR Jr., McCracken GH Jr. Management of infections caused by
antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-382.
126. Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi J L.
Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups А, В, С,
and G) and Streptococcus milled: a multicenter study in France. Arch Intern Med
2002; 162:2450-2456.
127. Sambola A, Miro JM, Tornos MP, Almirante B, Moreno-Torrico A, Gurgui M, Martinez
E, Del Rio A, Azqueta M, Marco F, Gatell JM. Streptococcus agalactiae infective endocarditis:
analysis of 30 cases and review of the literature, 1962-1998. Clin Infect Dis 2002;34:1576-
1584.
128. Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: therapeutic
dilemma. Rev Infect Dis 1987;9:908-916.
129. Lin CH, Hsu RB. Infective endocarditis caused by nutritionally variant streptococci. Am
JMed Sci 2007;334:235-239.
130. Cone LA, Sontz EM, Wilson JW, Mitruka SN. Staphylococcus capitis endocarditis due
to a transvenous endocardial pacemaker infection: case report and review of Staphylococcus
capitis endocarditis. Int J Infect Dis 2005;9:335-339.
131. Sandoe JA, Kerr KG, Reynolds GW, Jain S. Staphylococcus capitis endocarditis: two
cases and review of the literature. Heart 1999;82:el.
132. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus
aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study.
Ann Intern Med 1982;97:496-503.
133. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP,
Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low-dose gentamicin for
Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009;48:713-
721.
134. Chirouze C, Cabell CH, Fowler VG Jr, Khayat N, Olaison L, Miro JM, Habib G,
Abrutyn E, Eykyn S, Corey GR, Selton-Suty С, Ноеп В. Prognostic factors in 61 cases of
Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration
on Endocarditis merged database. Clin Infect Dis 2004;38:1323-1327.
135. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment
74
of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-1541.
136. O'Connor S, Andrew P, Bart M, Becquemin JP. A systematic review and meta-
analysis of treatments for aortic graft infection. J Vase Surg 2006; 44: 38-45.
137. Riedel DJ, Weekes E, Forrest GN. Addition of rifampin to standard therapy for treatment
of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents
Chemother 2008;52:2463-2467.
138. Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK. Isolates with low-level
vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus
bacteremia. Antimicrob Agents Chemother 2006;50:3039-3047.
139. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine
DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG,
Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fatkenheuer G, Gareca
M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE. Daptomycin versus standard therapy for
bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-665.
140. Levine DP, Lamp КС. Daptomycin in the treatment of patients with infective
endocarditis: experience from a registry. Am J Med 2007; 120:S28-S33.
141. Rose WE, Leonard SN, Sakoulas G, Kaatz GW, Zervos MJ, Sheth A, Carpenter
CF, Rybak MJ. Daptomycin activity against Staphylococcus aureus following vancomycin
exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Antimicrob Agents Chemother 2008;52:831-836.
142. Guignard B, Entenza JM, Moreillon P. Beta-lactams against methicillin-resistant
Staphylococcus aureus. Curr Opin Pharmacol 2005;5:479-489.
143. Vouillamoz J, Entenza JM, Feger C, Glauser MP, Moreillon P. Quinupristin-dal fopristin
combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus
aureus constitutively resistant to macrolidelincosamide-streptogramin В antibiotics. Antimicrob
Agents Chemother 2000; 44:1789-1795.
144. Jacqueline C, Navas D, Batard E, Miegeville AF, Le Mabecque V, Kergueris MF,
Bugnon D, Potel G, Caillon J. In vitro and in vivo synergistic activities of linezolid combined with
subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother 2005;49:45-51.
145. Perichon B, Courvalin P. Synergism between beta-lactams and glycopeptides
against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of
the vanA operon. Antimicrob Agents Chemother 2006;50:3622-3630.
146. Reynolds R, Potz N, Colman M, Williams A, Livermore D, MacGowan A.
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the
BSAC Bacteraemia Resistance Surveillance Programme. J Antimicrob Chemother
2004;53:1018-1032.
147. Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: can shorter
therapy with aminoglycosides be used? Clin Infect Dis 2002;34:159-166.
148. Gavalda J, Len O, Miro JM, Munoz P, Montejo M, Alarcon A, de la Torre-
Cisneros J, Pena C, Martinez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J,
Marco F, Torres C, Tornos P, Planes A, Falco V, Almirante B, Pahissa A. Brief
communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
Ann Intern Med 2007;146:574-579.
149. Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis
caused by HACEK microorganisms. Annu Rev Med 1997;48:25-33.
150. Paturel L, Casalta JP, Habib G, Nezri M, Raoult D. Actinobacillus
actinomycetemcomitans endocarditis. Clin Microbiol Infect 2004; 10:98-118.
151.Morpeth S Jr., Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernandez-Hidalgo N, Dickerman S, Bouza E, Del Rio A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG
75
Jr. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med 2007; 147: 829-835.
152. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center:
etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005;84:162-173.
153. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol
Rev2001;14:177-207.
154. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis:
evidence in the world literature, 1965-1995. Clin Infect Dis 2001;32:50-62.
155. Garzoni C, Nobre VA, Garbino J. Candida parapsilosis endocarditis: a comparative
review of the literature. Eur J Clin Microbiol Infect Dis 2007;26:915-926.
156. Lye DC, Hughes A, O'Brien D, Athan E. Candida glabrata prosthetic valve endocarditis
treated successfully with fluconazole plus caspofungin without surgery: a case report and literature
review. Eur J Clin Microbiol Infect Dis 2005;24:753-755.
157. Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in
adults: how many blood cultures are needed? J Clin Microbiol 2007; 45: 3546-3548.
158. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB,
Kunkel MJ, Yancey RW, Williams DN. Practice guidelines for outpatient parenteral antimicrobial
therapy. IDSA guidelines. Clin Infect Dis 2004;38:1651-1672.
159. Andrews MM, von Reyn CF. Patient selection criteria and management guidelines for
outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis
2001;33:203-209.
160. Monteiro С A, Cobbs CG. Outpatient management of infective endocarditis. Curr Infect
DisRep2001;3:319-327.
161. Huminer D, Bishara J, Pitlik S. Home intravenous antibiotic therapy for patients with
infective endocarditis. Eur J Clin Microbiol Infect Dis 1999;18:330-334.
162. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods
CW, Engemann JJ, Corey GR, Harding T, Cabell CH. Early surgery in patients with infective
endocarditis: a propensity score analysis. Clin Infect Dis 2007;44:364-372.
163. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-
month mortality in adults with complicated, left-sided native valve endocarditis: a propensity
analysis. JAMA2003;290:3207-3214.
164. Delahaye F, Celard M, Roth O, de Gevigney G. Indications and optimal timing for
surgery in infective endocarditis. Heart 2004;90:618-620.
165. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, Giorgi R, Gouriet
F, Tafanelli L, Avierinos JF, Renard S, Collart F, Raoult D, Habib G. The timing of surgery
influences mortality and morbidity in adults with severe complicated infective endocarditis: a
propensity analysis. Eur Heart J 2009; in press.
166. Di Salvo G, Thuny F, Rosenberg V, Pergola V, Belliard O, Derumeaux G,Cohen
A, Iarussi D, Giorgi R, Casalta JP, Caso P, Habib G. Endocarditis in the elderly: clinical,
echocardiographic, and prognostic features. Eur Heart J 2003; 24:1576-1583.
167. Habib G, Avierinos JF, Thuny F. Aortic valve endocarditis: is there an optimal surgical
timing? Curr Opin Cardiol 2007;22:77-83.
168. Piper C, Hetzer R, Korfer R, Bergemann R, Horstkotte D. The importance of secondary
mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation.
Eur Heart J2002;23:79-86.
169. De Castro S, d'Amati G, Cartoni D, Venditti M, Magni G, Gallo P, Beni S,
Fiorelli M, Fedele F, Pandian NG. Valvular perforation in left-sided infective endocarditis: a
prospective echocardiographic evaluation and clinical outcome. Am Heart J 1997; 134:656-664.
170. Vilacosta I, San Roman JA, Sarria C, Iturralde E, Graupner C, Batlle E, Peral V,
Aragoncillo P, Stoermann W. Clinical, anatomic, and echocardiographic characteristics of
aneurysms of the mitral valve. Am J Cardiol 1999;84:110-113, Al 19.
171. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA,
Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A,
76
Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550.
172. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL,
Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT,
Rakowski H, Thys DM. ACC/AHA/ASE 2003 guideline update for the clinical application of
echocardiography-summary article: a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the
1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol
2003;42: 954-970.
173. Kahveci G, Bayrak F, Mutlu B, Bitigen A, Karaahmet T, Sonmez K, Izgi A,
Degertekin M, Basaran Y. Prognostic value of N-terminal pro-B-type natriuretic peptide in
patients with active infective endocarditis. Am J Cardiol 2007;99: 1429-1433.
174. Miro JM Jr., Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn
S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VG Jr. Staphylococcus aureus native valve
infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis
Merged Database. Clin Infect Dis 2005;41: 507-514.
175. Bouza E, Menasalvas A, Munoz P, Vasallo FJ, del Mar Moreno M, Garcia
Fernandez MA. Infective endocarditis—a prospective study at the end of the twentieth century: new
predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore)
2001;80:298-307.
176. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G,
Flachskampf F, Hall R, lung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A.
Guidelines on the management of valvular heart disease: the Task Force on the Management of
Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268.
177. Anguera I, Miro JM, Evangelista A, Cabell CH, San Roman JA, Vilacosta I,
Almirante B, Ripoll T, Farinas MC, Anguita M, Navas E, Gonzalez-Juanatey C, Garcia-Bolao I,
Munoz P, de Alarcon A, Sarria C, Rufi G, Miralles F, Pare C, Fowler VG Jr, Mestres CA, de
Lazzari E, Guma JR, Moreno A, Corey GR. Periannular complications in infective endocarditis
involving native aortic valves. Am J Cardiol 2006;98:1254-1260.
178. Anguera I, Miro JM, San Roman JA, de Alarcon A, Anguita M, Almirante B,
Evangelista A, Cabell CH, Vilacosta I, Ripoll T, Munoz P, Navas E, Gonzalez-
Juanatey C, Sarria C, Garcia-Bolao I, Farinas MC, Rufi G, Miralles F, Pare C, Fowler VG Jr,
Mestres CA, de Lazzari E, Guma JR, Del Rio A, Corey GR. Periannular complications in
infective endocarditis involving prosthetic aortic valves. Am J Cardiol 2006;98:1261-1268.
179. Daniel WG, Flachskampf FA. Infective endocarditis. In: Camm AJ, Lu'scher TF,
Serruys PWeds. The ESC textbook of cardiovascular medicine. Oxford: Blackwell Publishing;
2006. p671-684.
180. Leung DY, Cranney GB, Hopkins AP, Walsh WF. Role of transoesophageal
echocardiography in the diagnosis and management of aortic root abscess. Br Heart J
1994;72:175-181.
181. Graupner C, Vilacosta I, SanRoman J, Ronderos R, Sarria C, Fernandez C,
Mujica R, Sanz O, Sanmartin JV, Pinto AG. Periannular extension of infective endocarditis. J Am
Coll Cardiol 2002;39:1204-1211.
182. Lengyel M. The impact of transesophageal echocardiography on the management of
prosthetic valve endocarditis: experience of 31 cases and review of the literature. J Heart Valve Dis
1997;6:204-211.
183. Karalis DG, Bansal RC, Hauck AJ, Ross JJJ, Applegate PM, Jutzy KR, Mintz GS,
Chandrasekaran K. Transesophageal echocardiographic recognition of subaortic complications in
aortic valve endocarditis. Clinical and surgical implications. Circulation 1992;86:353-362.
184. Chan KL. Early clinical course and long-term outcome of patients with infective
77
endocarditis complicated by perivalvular abscess. CMAJ 2002;167:19-24.
185. Tingleff J, Egeblad H, Gotzsche CO, Baandrup U, Kristensen BO, Pilegaard H,
Pettersson G. Perivalvular cavities in endocarditis: abscesses versus pseudoaneurysms? A
transesophageal Doppler echocardiographic study in 118 patients with endocarditis. Am Heart J
1995;130:93-100.
186. Anguera I, Miro JM, Vilacosta I, Almirante B, Anguita M, Munoz P, Roman JA, de
Alarcon A, Ripoll T, Navas E, Gonzalez-Juanatey C, Cabell CH, Sarria C, Garcia-Bolao I,
Farinas MC, Leta R, Rufi G, Miralles F, Pare C, Evangelista A, Fowler VG Jr, Mestres CA, de
Lazzari E, Guma JR. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical
and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005;26:288-
297.
187. Jenkins NP, Habib G, Prendergast BD. Aorto-cavitary fistulae in infective endocarditis:
understanding a rare complication through collaboration. Eur Heart J 2005;26:213-214.
188. Bashore TM Jr., Cabell C, Fowler V Jr. Update on infective endocarditis. Curr Probl
Cardiol 2006;31:274-352.
189. Manzano MC, Vilacosta I, San Roman JA, Aragoncillo P, Sarria C, Lopez D,
Lopez J, Revilla A, Manchado R, Hernandez R, Rodriguez E. [Acute coronary syndrome in
infective endocarditis]. Rev Esp Cardiol 2007;60:24-31.
190. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment of complicated prosthetic
aortic valve endocarditis with annular abscess formation by homograft aortic root replacement. J
Am Coll Cardiol 1991;17:1177-1182.
191. Knosalla C, Weng Y, Yankah AC, Siniawski H, Hofmeister J, Hammerschmidt R, Loebe
M, Hetzer R. Surgical treatment of active infective aortic valve endocarditis with associated
periannular abscess—11 year results. Eur Heart J 2000;21:490-497.
192. Bishara J, Leibovici L, Gartman-Israel D, Sagie A, Kazakov A, Miroshnik E,
Ashkenazi S, Pitlik S. Long-term outcome of infective endocarditis: the impact of early surgical
intervention. Clin Infect Dis 2001 ;3 3:1636-1643.
193. Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP, Peltier M,
Tribouilloy С Predictors of death and impact of surgery in Staphylococcus aureus infective
endocarditis. AnnThorac Surg2007;83:1295-1302.
194. Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, Brahim A,
Nadji G, Riberi A, Collart F, Renard S, Raoult D, Habib G. Impact of cerebrovascular
complications on mortality and neurologic outcome during infective endocarditis: a prospective
multicentre study. Eur Heart J 2007;28:1155-1161.
195. Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM,
Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R.
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol
2001;37:1069-1076.
196. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP,
Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognostic value of
echocardiography. Ann Intern Med 1991;114:635-640.
197. De Castro S, Magni G, Beni S, Cartoni D, Fiorelli M, Venditti M, Schwartz SL, Fedele
F, Pandian NG. Role of transthoracic and transesophageal echocardiography in predicting embolic
events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol
1997;80:1030-1034.
198. Heinle S, Wilderman N, Harrison JK, Waugh R, Bashore T, Nicely LM, Durack D,
Kisslo J. Value of transthoracic echocardiography in predicting embolic events in active infective
endocarditis. Duke Endocarditis Service. Am J Cardiol 1994;74:799-801.
199. Rohmann S, Erbel R, Gorge G, Makowski T, Mohr-Kahaly S, Nixdorff U,
Drexler M, Meyer J. Clinical relevance of vegetation localization by transoesophageal
echocardiography in infective endocarditis. Eur Heart J 1992;13: 446-452.
200. Vilacosta I, Graupner C, San Roman JA, Sarria C, Ronderos R, Fernandez C, Mancini L,
78
Sanz O, Sanmartin JV, Stoermann W. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39: 1489-1495.
201. Erbel R, Liu F, Ge J, Rohmann S, Kupferwasser I. Identification of high-risk subgroups
in infective endocarditis and the role of echocardiography. Eur Heart J 1995; 16:588-602.
202. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD,
Weyman AE. Echocardiographic assessment of patients with infectious endocarditis: prediction of
risk for complications. J Am Coll Cardiol 1991;18:1191-1199.
203. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective
endocarditis: reassessment of prognostic implications of vegetation size determined by the
transthoracic and the transesophageal approach. J Am Coll Cardiol 1989; 14:631-638.
204. Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A,
Doco-Lecompte T, Eisen DP, Fortes CQ, Fowler VG Jr, Lerakis S, Miro JM, Pappas P,
Peterson GE, Rubinstein E, Sexton DJ, Suter F, Tornos P, Verhagen DW, Cabell CH.
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in
infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J
2007;154:1086-1094.
205. Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, Ryan T,
Lukes AS, Sexton DJ. The risk of stroke and death in patients with aortic and mitral valve
endocarditis. Am Heart J 2001;142:75-80.
206. Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict
clinical complications: a meta-analysis. J Am Soc Echocardiogr 1997;10: 562-568.
207. Rohmann S, Erbel R, Darius H, Gorge G, Makowski T, Zotz R, Mohr-Kahaly S,
Nixdorff U, Drexler M, Meyer J. Prediction of rapid versus prolonged healing of infective
endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991 ;4:465-474.
208. Pergola V, Di Salvo G, Habib G, Avierinos JF, Philip E, Vailloud JM, Thuny F, Casalta
JP, Ambrosi P, Lambert M, Riberi A, Ferracci A, Mesana T, Metras D, Harle JR, Weiller PJ, Raoult
D, Luccioni R. Comparison of clinical and echocardiographic characteristics of Streptococcus bovis
endocarditis with that caused by other pathogens. Am J Cardiol 2001;88:871-875.
209. Durante Mangoni E, Adinolfi LE, Tripodi MF, Andreana A, Gambardella M,
Ragone E, Precone DF, Utili R, Ruggiero G. Risk factors for 'major' embolic events in
hospitalized patients with infective endocarditis. Am Heart J 2003; 146:311-316.
210. Fabri J Jr, Issa VS, Pomerantzeff PM, Grinberg M, Barretto AC, Mansur AJ. Time
related distribution, risk factors and prognostic influence of embolism in patients with left-sided
infective endocarditis. Int J Cardiol 2006;l 10:334-339.
211. Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H. The presence
of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk
factor for embolic events. J Am Coll Cardiol 1999;33:1365-1371.
212. Anavekar NS, Tleyjeh IM, Mirzoyev Z, Steckelberg JM, Haddad C,
Khandaker MH, Wilson WR, Chandrasekaran K, Baddour LM. Impact of prior antiplatelet therapy
on risk of embolism in infective endocarditis. Clin Infect Dis2007;44:1180-1186.
213. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher
D. A randomized trial of aspirin on the risk of embolic events in patients with infective
endocarditis. J Am Coll Cardiol 2003;42:775-780.
214. Shapira Y, Weisenberg DE, Vaturi M, Sharoni E, Raanani E, Sahar G, Vidne В A, Battler
A, Sagie A. The impact of intraoperative transesophageal echocardiography in infective
endocarditis. Isr Med Assoc J 2007;9:299-302.
215. Acar С Early surgery in mitral valve endocarditis: it is sometimes too early. Eur J
Cardiothorac Surg 2007;32:947; author reply 948.
216. de Kerchove L, Vanoverschelde JL, Poncelet A, Glineur D, Rubay J, Zech F,
Noirhomme P, El Khoury G. Reconstructive surgery in active mitral valve endocarditis: feasibility,
safety and durability. Eur J Cardiothorac Surg 2007;31:592-599.
217. Edwards MB, Ratnatunga CP, Dore CJ, Taylor KM. Thirty-day mortality and longterm
79
survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry. Eur J Cardiothorac Surg 1998;14:156-164.
218. Dreyfus G, Serraf A, Jebara VA, Deloche A, Chauvaud S, Couetil JP,
Carpentier A. Valve repair in acute endocarditis. Ann Thorac Surg 1990;49:706-711;
discussion 712-703.
219. David ТЕ, Regesta T, Gavra G, Armstrong S, Maganti MD. Surgical treatment of
paravalvular abscess: long-term results. Eur J Cardiothorac Surg 2007;31:43-48.
220. Nataf P, Jault F, Dorent R, Vaissier E, Bors V, Pavie A, Cabrol C, Gandjbakhch I. Extra-
annular procedures in the surgical management of prosthetic valve endocarditis. Eur Heart J
1995;16SupplB:99-102.
221. Vistarini N, d'Alessandro C, Aubert S, Jault F, Acar C, Pavie A, Gandjbakhch I. Surgery
for infective endocarditis on mitral annulus calcification. J Heart Valve Dis 2007;16:611-616.
222. Ali M, lung B, Lansac E, Bruneval P, Acar C. Homograft replacement of the mitral
valve: eight-year results. J Thorac Cardiovasc Surg 2004; 128:529-534.
223.Kabbani S, Jamil H, Nabhani F, Hamoud A, Katan K, Sabbagh N, Koudsi A, Kabbani L, Hamed G. Analysis of 92 mitral pulmonary autograft replacement (Ross II) operations. J Thorac Cardiovasc Surg 2007; 134:902-908.
224. Lopes S, Calvinho P, de Oliveira F, Antunes M. Allograft aortic root replacement in
complex prosthetic endocarditis. Eur J Cardiothorac Surg 2007;32:126-130; discussion 131-132.
225. Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM. Aortic
root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg
2002;74:650-659; discussion 659.
226. Avierinos JF, Thuny F, Chalvignac V, Giorgi R, Tafanelli L, Casalta JP, Raoult D,
Mesana T, Collart F, Metras D, Habib G, Riberi A. Surgical treatment of active aortic endocarditis:
homografts are not the cornerstone of outcome. Ann Thorac Surg 2007;84:1935-1942.
227. Krasopoulos G, David ТЕ, Armstrong S. Custom-tailored valved conduit for
complex aortic root disease. J Thorac Cardiovasc Surg 2008;135:3-7.
228. Guerra JM, Tornos MP, Permanyer-Miralda G, Almirante B, Murtra M, Soler-
Soler J. Long term results of mechanical prostheses for treatment of active infective
endocarditis. Heart 2001;86:63-68.
229. Takkenberg JJ, Klieverik LM, Bekkers JA, Kappetein AP, Roos JW, Eijkemans MJ,
Bogers AJ. Allografts for aortic valve or root replacement: insights from an 18-year single-
center prospective follow-up study. Eur J Cardiothorac Surg 2007; 31:851 -859.
230. Prat A, Fabre OH, Vincentelli A, Doisy V, Shaaban G. Ross operation and mitral
homograft for aortic and tricuspid valve endocarditis. Ann Thorac Surg 1998;65:1450-1452.
231. Schmidtke C, Dahmen G, Sievers HH. Subcoronary Ross procedure in patients with
active endocarditis. Ann Thorac Surg 2007;83:36-39.
232. Obadia JF, Henaine R, Bergerot C, Ginon I, Nataf P, Chavanis N, Robin J,
Andre-Fouet X, Ninet J, Raisky O. Monobloc aorto-mitral homograft or mechanical valve
replacement: a new surgical option for extensive bivalvular endocarditis. J Thorac Cardiovasc Surg
2006; 131:243-245.
233. Pavie A. Heart transplantation for end-stage valvular disease: indications and
results. Curr Opin Cardiol 2006;21:100-105.
234. Delay D, Pellerin M, Carrier M, Marchand R, Auger P, Perrault LP, Hebert Y, Cartier R,
Page P, Pelletier LC. Immediate and long-term results of valve replacement for native and
prosthetic valve endocarditis. Ann Thorac Surg 2000;70:1219-1223.
235. Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, Monro JL. Surgery for
active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg
2000;69:1448-1454.
236. Kaiser SP, Melby SJ, Zierer A, Schuessler RB, Moon MR, Moazami N, Pasque MK,
Huddleston C, Damiano RJ Jr, Lawton JS. Long-term outcomes in valve replacement surgery for
infective endocarditis. Ann Thorac Surg 2007;83:30-35.
80
237. David ТЕ, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical
treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg
2007;133:144-149.
238. Ruttmann E, Legit C, Poelzl G, Mueller S, Chevtchik O, Cottogni M, Ulmer H,
Pachinger O, Laufer G, Mueller LC. Mitral valve repair provides improved outcome over
replacement in active infective endocarditis. J Thorac Cardiovasc Surg 2005;130:765-771.
239. Thuny F, Beurtheret S, Gariboldi V, Mancini J, Avierinos JF, Riberi A, Casalta JP,
Gouriet F, Tafanelli L, Giorgi R, Collart F, Raoult D, Habib G. Outcome after surgical treatment
performed within the first week of antimicrobial therapy during infective endocarditis: a
prospective study. Arch Cardiovasc Dis 2008; 101:687-695.
240. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P.
Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in
Finland. Arch Intern Med 2000;160:2781-2787.
241. Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, Sexton
DJ. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis.
Neurology 2003;61:1341-1346.
242. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical
management of infective endocarditis associated with cerebral complications. Multicenter
retrospective study in Japan. J Thorac Cardiovasc Surg 1995;110:1745-1755.
243. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene
PS. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg
1996;61:1125-1129; discussion 1130.
244. Jault F, Gandjbakhch I, Rama A, Nectoux M, Bors V, Vaissier E, Nataf P, Pavie A,
Cabrol С Active native valve endocarditis: determinants of operative death and late mortality. Ann
Thorac Surg 1997;63:1737-1741.
245. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication for
urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-711.
246. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Hofer D, Poewe W, Laufer G, Muller LC.
Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke
2006;37:2094-2099.
247. Angstwurm K, Borges AC, Halle E, Schielke E, Einhaupl KM, Weber JR. Timing the
valve replacement in infective endocarditis involving the brain. J Neurol 2004;251:1220-1226.
248. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective
endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern
Medl999;159:473-475.
249. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG,
Bayer AS. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial
dissemination, and frequency of embolic events in experimental Staphylococcus aureus
endocarditis through antiplatelet and antibacterial effects. Circulation 1999;99:2791-2797.
250. Kupferwasser LI, Yeaman MR, Nast CC, Kupferwasser D, Xiong YQ, Palma M, Cheung
AL, Bayer AS. Salicylic acid attenuates virulence in endovascular infections by targeting global
regulatory pathways in Staphylococcus aureus. J Clin Invest 2003;l 12:222-233.
251. Nicolau DP, Tessier PR, Nightingale CH. Beneficial effect of combination antiplatelet
therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob
Agents 1999;11:159-161.
252. Chan KL, Tarn J, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek M, Robinson T,
Williams K. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect
Dis2008;46:37-41.
253. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;
345:1318-1330.
254. Peters PJ, Harrison T, Lennox JL. A dangerous dilemma: management of infectious
intracranial aneurysms complicating endocarditis. Lancet Infect Dis 2006;6:742-748.
81
255. Corr P, Wright M, Handler LC. Endocarditis-related cerebral aneurysms: radiologic
changes with treatment. AJNR Am J Neuroradiol 1995;16:745-748.
256. Pruitt AA, Rubin RH, Karchmer AW, Duncan GW. Neurologic complications of
bacterial endocarditis. Medicine (Baltimore) 1978;57:329-343.
257. Huston J 3rd, Nichols DA, Luetmer PH, Goodwin JT, Meyer FB, Wiebers DO, Weaver
AL. Blinded prospective evaluation of sensitivity of MR angiography to known intracranial
aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol 1994;15:1607-1614.
258. White PM, Teasdale EM, Wardlaw JM, Easton V. Intracranial aneurysms: CT
angiography and MR angiography for detection prospective blinded comparison in a large patient
cohort. Radiology 2001;219:739-749.
259. Ahmadi J, Tung H, Giannotta SL, Destian S. Monitoring of infectious intracranial
aneurysms by sequential computed tomographic/magnetic resonance imaging studies.
Neurosurgery 1993;32:45-49; discussion 49-50.
260. Chapot R, Houdart E, Saint-Maurice JP, Aymard A, Mounayer C, Lot G, Merland
JJ. Endovascular treatment of cerebral mycotic aneurysms. Radiology 2002;222:389-396.
261. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA.
Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol
1998;49:96-101.
262. Majumdar A, Chowdhary S, Ferreira MA, Hammond LA, Howie AJ, Lipkin GW, Littler
WA. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant
2000;15:1782-1787.
263. Wolff M, Witchitz S, Chastang C, RegnierB, Vachon F. Prosthetic valve endocarditis in
the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for
treatment decision. Chest 1995; 108:688-694.
264. Gonzalez-Juanatey C, Gonzalez-Gay MA, Llorca J, Crespo F, Garcia-Porrua C,
Corredoira J, Vidan J, Gonzalez-Juanatey JR. Rheumatic manifestations of infective endocarditis in
non-addicts. A 12-year study. Medicine (Baltimore) 2001;80:9-19.
265. Morelli S, Carmenini E, Caporossi AP, Aguglia G, Bernardo ML, Gurgo AM.
Spondylodiscitis and infective endocarditis: case studies and review of the literature. Spine
2001;26:499-500.
266. Le Moal G, Roblot F, Paccalin M, Sosner P, Burucoa C, Roblot P, Becq-
Giraudon B. Clinical and laboratory characteristics of infective endocarditis when associated with
spondylodiscitis. Eur J Clin Microbiol Infect Dis 2002;21: 671-675.
267. Pigrau C, Almirante B, Flores X, Falco V, Rodriguez D, Gasser I, Villanueva C, Pahissa
A. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and
outcome. Am JMed 2005; 118:1287.
268. Lerner RM, Spataro RF. Splenic abscess: percutaneous drainage. Radiology 1984;
153:643-645.
269. Chou YH, Hsu CC, Tiu CM, Chang T. Splenic abscess: sonographic diagnosis and
percutaneous drainage or aspiration. Gastrointest Radiol 1992;17:262-266.
270. Sexton DJ, Spelman D. Current best practices and guidelines. Assessment and
management of complications in infective endocarditis. Infect Dis Clin North Am 2002;16:507-521.
271. Steckelberg JM, Murphy JG, Wilson WR. Management of complications of infective
endocarditis. In: Kaye D, ed. Infective endocarditis. New York: Raven Press; 1992. p435-453.
272. Martinez-Selles M, Munoz P, Estevez A, del Castillo R, Garcia-Fernandez MA,
Rodriguez-Creixems M, Moreno M, Bouza E. Long-term outcome of infective endocarditis in non-
intravenous drug users. Mayo Clin Proc 2008;83:1213-1217.
273. Heiro M, Helenius H, Hurme S, Savunen T, Metsarinne K, Engblom E,
Nikoskelainen J, Kotilainen P. Long-term outcome of infective endocarditis: a study on patients
surviving over one year after the initial episode treated in a Finnish teaching hospital during 25
years. ВМС Infect Dis 2008;8:49.
274. Tornos MP, Permanyer-Miralda G, Olona M, Gil M, Galve E, Almirante B, Soler-
82
Soler J. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med 1992;117:567-572.
275. Mansur AJ, Dal Bo CM, Fukushima JT, Issa VS, Grinberg M, Pomerantzeff PM.
Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after
infective endocarditis. Am Heart J 2001;141:78-86.
276. Baddour LM. Twelve-year review of recurrent native-valve infective endocaditis: a
disease of the modern antibiotic era. Rev Infect Dis 1988; 10:1163-1170.
277. Heiro M, Helenius H, Makila S, Hohenthal U, Savunen T, Engblom E,
Nikoskelainen J, Kotilainen P. Infective endocarditis in a Finnish teaching hospital: a study on 326
episodes treated during 1980-2004. Heart 2006;92:1457-1462.
278. Hagl C, Galla JD, Lansman SL, Fink D, Bodian CA, Spielvogel D, Griepp RB.
Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using
prosthetic material contraindicated? Ann Thorac Surg 2002;74:S1781-S1785; discussion S1792-
S1799.
279. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med
1996;335:407-416.
280. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approach and
therapeutic options. Prog Cardiovasc Dis 2008;50:274-281.
281. Piper C, Korfer R, HorstkotteD. Prosthetic valve endocarditis. Heart 2001;85:590-593.
282. Mahesh B, Angelini G, Caputo M, Jin XY, Bryan A. Prosthetic valve endocarditis. Ann
Thorac Surg 2005;80:1151-1158.
283. Habib G, Tribouilloy C, Thuny F, Giorgi R, Brahim A, Amazouz M, Remadi JP, Nadji
G, Casalta JP, Coviaux F, Avierinos JF, Lescure X, Riberi A, Weiller PJ, Metras D, Raoult D.
Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart
2005;91:954-959.
284. Lopez J, Revilla A, Vilacosta I, Villacorta E, Gonzalez-Juanatey C, Gomez I,
Rollan MJ, San Roman JA. Definition, clinical profile, microbiological spectrum, and prognostic
factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007;28:760-765.
285. Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, Garcia M, Lefevre
J, Biou F, Maximovitch-Rodaminoff A, Fournier PE, Ambrosi P, Velut JG, Cribier A, Harle
JR, Weiller PJ, Raoult D, Luccioni R. Value and limitations of the Duke criteria for the diagnosis of
infective endocarditis. J Am Coll Cardiol 1999;33:2023-2029.
286. Lamas CC, Eykyn SJ. Suggested modifications to the Duke criteria for the clinical
diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven
cases. Clin Infect Dis 1997;25:713-719.
287. Perez-Vazquez A, Farinas MC, Garcia-Palomo JD, Bernal JM, Revuelta JM,
Gonzalez-Macias J. Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis:
could sensitivity be improved? Arch Intern Med 2000;160:1185-1191.
288. Tornos P, Almirante B, Olona M, Permanyer G, Gonzalez T, Carballo J, Pahissa
A, Soler-Soler J. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a
20-year experience. Clin Infect Dis 1997;24:381-386.
289. Akowuah EF, Davies W, Oliver S, Stephens J, Riaz I, Zadik P, Cooper G. Prosthetic
valve endocarditis: early and late outcome following medical or surgical treatment. Heart
2003;89:269-272.
290. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus
aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis
1998;26:1302-1309.
291. Gordon SM 3rd, Serkey JM, Longworth DL, Lytle BW, Cosgrove DM 3rd. Early onset
prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997. Ann Thorac Surg
2000;69:1388-1392.
292. Sohail MR, Martin KR, Wilson WR, Baddour LM, Harmsen WS, Steckelberg JM.
Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J
83
Med2006;119:147-154.
293. Wang A, Pappas P, Anstrom KJ, Abrutyn E, Fowler VG Jr, Hoen B, Mro JM, Corey
GR, Olaison L, Stafford JA, Mestres CA, Cabell CH. The use and effect of surgical therapy for
prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort.
AmHeart J 2005;150:1086-1091.
294. Truninger K, Attenhofer Jost CH, Seifert B, Vogt PR, Follath F, Schaffner A,
Jenni R. Long term follow up of prosthetic valve endocarditis: what characteristics identify
patients who were treated successfully with antibiotics alone? Heart 1999;82:714-720.
295. Hill ЕЕ, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P.
Management of prosthetic valve infective endocarditis. Am J Cardiol 2008;101:1174-1178.
296. Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker
endocarditis during 18 years in Goteborg. Scand J Infect Dis 2004;36:674-679.
297. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferried P, Gerber MA,
Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS,
Falace DA, Shulman ST, Tani LY, Taubert KA. Nonvalvular cardiovascular device-related
infections. Circulation 2003;108:2015-2031.
298. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM,
Wilson WR, Steckelberg JM, Baddour LM. Permanent pacemaker and implantable cardioverter
defibrillator infection: a population-based study. Arch Intern Med 2007;167:669-675.
299. Duval X, Selton-Suty C, Alia F, Salvador-Mazenq M, Bernard Y, Weber M,
Lacassin F, Nazeyrolas P, Chidiac C, Hoen B, Leport С Endocarditis in patients with a permanent
pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or
pacemaker infection. Clin Infect Dis 2004;39: 68-74.
300. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR,
Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and
implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-1859.
301. Klug D, Wallet F, Lacroix D, Marquie C, Kouakam C, Kacet S, Courcol R. Local
symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart
2004;90:882-886.
302. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR,
Steckelberg JM, Jenkins SM, Baddour LM. Infective endocarditis complicating permanent
pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc2008;83:46-53.
303. Da Costa A, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F,
Etienne J, Touboul P. Role of the preaxillary flora in pacemaker infections: a prospective study.
Circulation 1998;97:1791-1795.
304. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL,
Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S. Risk factors related to
infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective
study. Circulation2007;l 16:1349-1355.
305. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet
S, Lekieffre J. Systemic infection related to endocarditis on pacemaker leads: clinical
presentation and management. Circulation 1997;95:2098-2107.
306. CacoubP, Leprince P, Nataf P, Hausfater P, DorentR, Wechsler B, Bors V, Pavie A,
Piette JC, Gandjbakhch I. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-484.
307. Vilacosta I, Sarria C, San Roman JA, Jimenez J, Castillo JA, Iturralde E, Rollan MJ,
Martinez Elbal L. Usefulness of transesophageal echocardiography for diagnosis of infected
transvenous permanent pacemakers. Circulation 1994;89:2684-2687.
308. Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D, Mabo P, Daubert С
Pacemaker lead infection: echocardiographic features, management, and outcome. Heart
1999;81:82-87.
309. Dalai A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac
echocardiography in the detection of pacemaker lead endocarditis. J Am Soc Echocardiogr
84
2002;15:1027-1028.
310. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133:604-608.
311.Dumont E, Camus C, Victor F, de Place C, Pavin D, Alonso C, Mabo P, Daubert JC. Suspected pacemaker or defibrillator transvenous lead infection. Prospective assessment of a TEE-guided therapeutic strategy. Eur Heart J 2003; 24:1779-1787.
312. Love CJ, Wilkoff BL, Byrd CL, Belott PH, Blinker JA, Fearnot NE, Friedman RA,
Furman S, Goode LB, Hayes DL, Kawanishi DT, Parsonnet V, Reiser C, Van Zandt HJ.
Recommendations for extraction of chronically implanted transvenous pacing and defibrillator
leads: indications, facilities, training. North American Society of Pacing and
Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000;23:544-
551.
313. Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads
with infected vegetations: a single-center experience and consequences of transvenous extraction.
Am Heart J 2003;146:339-344.
314. Ruttmann E, Hangler HB, Kilo J, Hofer D, Muller LC, Hintringer F, Muller S, Laufer G,
Antretter H. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an
analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 2006;29:231-236.
315. Del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M, Mestres С А
Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead
extraction on outcome. Chest 2003;124:1451-1459.
316. Bracke FA, Meijer A, van Gelder LM. Pacemaker lead complications: when is extraction
appropriate and what can we learn from published data? Heart 2001 ;85:254-259.
317. Jenkins SM, Hawkins NM, Hogg KJ. Pacemaker endocarditis in patients with
prosthetic valve replacements: case trilogy and literature review. Pacing Clin Electrophysiol
2007;30:1279-1283.
318. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz
K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis.
Circulation 1998;97:1796-1801.
319. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of
proposed mechanisms of pathogenesis. Clin Infect Dis 2000;30:374-379.
320. Wilson LE, Thomas DL, Astemborski J, Freedman TL, Vlahov D. Prospective study of
infective endocarditis among injection drug users. J Infect Dis 2002; 185:1761-1766.
321. Cooper HL, Brady JE, Ciccarone D, Tempalski B, Gostnell K, Friedman SR.
Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective
endocarditis. ClinInfectDis2007;45:1200-1203.
322. Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk
factors for clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV
cohort. J Acquir Immune Defic Syndr 2006;43:426-432.
323. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003;89:577-
581.
324. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features,
site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous
drug users. Arch Intern Med 1995;155:1641-1648.
325. Graves MK, Soto L. Left-sided endocarditis in parenteral drug abusers: recent experience
at a large community hospital. South Med J 1992;85:378-380.
326. San Roman JA, Vilacosta I, Sarria C, Garcimartin I, Rollan MJ, Fernandez-Aviles F.
Eustachian valve endocarditis: is it worth searching for? Am Heart J 2001;142:1037-1040.
327. Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in
intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003;21:167-184, v-vi.
328. Chambers HF, Korzeniowski OM, Sande MA. Staphylococcus aureus endocarditis:
85
clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 1983;62:170-177.
329. San Roman JA, Vilacosta I, Zamorano JL, Almeria C, Sanchez-Harguindey L.
Transesophageal echocardiography in right-sided endocarditis. J Am Coll Cardiol 1993;21:1226-
1230.
330. San Roman JA, Vilacosta I. Role of transesophageal echocardiography in rightsided
endocarditis. Echocardiography 1995; 12:669-672.
331. Herrera CJ, Mehlman DJ, Hartz RS, Talano JV, McPherson DD. Comparison of
transesophageal and transthoracic echocardiography for diagnosis of right-sided cardiac lesions.
Am J Cardiol 1992;70:964-966.
332. Winslow T, Foster E, Adams JR, Schiller NB. Pulmonary valve endocarditis:
improved diagnosis with biplane transesophageal echocardiography. J Am Soc Echocardiogr
1992;5:206-210.
333. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical
assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993;119:1017-1028.
334. Haverkos HW, Lange WR. From the Alcohol, Drug Abuse, and Mental Health
Administration. Serious infections other than human immunodeficiency virus among
intravenous drug abusers. J Infect Dis 1990;161:894-902.
335. Martin-Davila P, Navas E, Fortun J, Moya JL, Cobo J, Pintado V, Quereda C, Jimenez-
Mena M, Moreno S. Analysis of mortality and risk factors associated with native valve endocarditis
in drug users: the importance of vegetation size. Am Heart J 2005;150:1099-l 106.
336. Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the
Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev
Infect Dis 1986;8:364-373.
337. Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical
Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 1986;8:374-396.
338. Botsford KB, Weinstein RA, Nathan CR, Kabins SA. Selective survival in pentazocine
and tripelennamine of Pseudomonas aeruginosa serotype Oil from drug addicts. J Infect Dis
1985;151:209-216.
339. Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, de la Bellacasa JP,
Soriano E. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and
review. Clin Infect Dis 1992;15:910-923.
340. Fortun J, Navas E, Martinez-Beltran J, Perez-Molina J, Martin-Davila P,
Guerrero A, Moreno S. Short-course therapy for right-sided endocarditis due to Staphylococcus
aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin
Infect Dis 2001;33:120-125.
341. Ribera E, Gomez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T,
Almirante B, Ocana I, Pahissa A. Effectiveness of cloxacillin with and without gentamicin in short-
term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.
Ann Intern Med 1996;125:969-974.
342. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus
endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med
1988;109:619-624.
343. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by
Staphylococcus aureus in injection drug users. Ann Intern Med 1994;121: 873-876.
344. Rubinstein E, Carbon С Staphylococcal endocarditis - recommendations for therapy.
Clin Microbiol Infect 1998;4 Suppl 3:S27-S33.
345. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic
features in 102 episodes. Ann Intern Med 1992;117:560-566.
346. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in
intravenous drug users. Antimicrob Agents Chemother 1990;34:1227-1231.
347. Fortun J, Perez-Molina JA, Anon MT, Martinez-Beltran J, Loza E, Guerrero A. Right-
sided endocarditis caused by Staphylococcus aureus in drug abusers. Antimicrob Agents Chemother
86
1995;39:525-528.
348. Pulvirenti JJ, Kerns E, Benson С, Lisowski J, Demarais P, Weinstein RA. Infective
endocarditis in injection drug users: importance of human immunodeficiency virus serostatus
and degree of immunosuppression. Clin Infect Dis 1996;22:40-45.
349. Nahass RG, Weinstein MP, Bartels J, Gocke DJ. Infective endocarditis in intravenous
drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients.
J Infect Dis 1990;162:967-970.
350. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski ТЕ, Pompili VJ, Sis son
SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner С
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users:
prospective randomized comparison with parenteral therapy. Am J Med 1996;101:68-76.
351. Working Party of the British Society for Antimicrobial Chemotherapy. Antibiotic
treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the
British Society for Antimicrobial Chemotherapy. Heart 1998;79:207-210.
352. Pettersson G, Carbon С Recommendations for the surgical treatment of endocarditis.
Clin Microbiol Infect 1998;4 Suppl 3:S34-S46.
353. Levine DP, Sobel JD. Infections in intravenous drug abusers. In: Mandell GL,
Douglas RG, Bennett JEeds. Principles and practice of infectious diseases. New York: Churchill
Livingstone; 1995. p2696-2709.
354. Lemma M, Vanelli P, Beretta L, Botta M, Antinori A, Santoli C. Cardiac surgery in
HIV-positive intravenous drug addicts: influence of cardiopulmonary bypass on the progression to
AIDS. Thorac Cardiovasc Surg 1992;40:279-282.
355. Aris A, Pomar JL, Saura E. Cardiopulmonary bypass in HIV-positive patients. Ann
Thorac Surg 1993;55:1104-1107; discussion 1107-1108.
356. Gottardi R, Bialy J, Devyatko E, Tschernich H, Czerny M, Wolner E,
Seitelberger R. Midterm follow-up of tricuspid valve reconstruction due to active infective
endocarditis. Ann Thorac Surg 2007;84:1943 -1948.
357. Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, Yankah CA,
Hetzer R. Surgical treatment of right-sided active infective endocarditis with or without
involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg
2007;32:118-125.
358. Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable right-sided infective
endocarditis in drug addicts: 25 years experience. J Heart Valve Dis 1993;2:129-137; discussion
138-139.
359. Miyagishima RT, Brumwell ML, Eric Jamieson WR, Munt BI. Tricuspid valve
replacement using a cryopreserved mitral homograft. Surgical technique and initial results. J Heart
Valve Dis 2000;9:805-808; discussion 808-809.
360. Mestres CA, Miro JM, Pare JC, Pomar JL. Six-year experience with cryopreserved
mitral homografts in the treatment of tricuspid valve endocarditis in HIV-infected drug addicts. J
Heart Valve Dis 1999;8:575-577.
361.Moller JH, Anderson RC. 1,000 consecutive children with a cardiac malformation with 26- to 37-year follow-up. Am J Cardiol 1992;70:661-667.
362. Niwa K, Nakazawa M, Tateno S, Yoshinaga M, Terai M. Infective endocarditis in
congenital heart disease: Japanese national collaboration study. Heart 2005;91:795-800.
363. Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur
Heart J 1995;16 Suppl B:2-6.
364. de Gevigney G, Pop C, Delahaye JP. The risk of infective endocarditis after
cardiac surgical and interventional procedures. Eur Heart J 1995; 16 Suppl B:7-14.
365. Roder BL, Wandall DA, Espersen F, Frimodt-Moller N, Skinhoj P, Rosdahl VT.
Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases
in nondrug addicts. Am J Med 1997;102:379-386.
366. Di Filippo S, Delahaye F, Semiond B, Celard M, Henaine R, Ninet J, Sassolas F, Bozio
87
A. Current patterns of infective endocarditis in congenital heart disease. Heart 2006;92:1490-1495.
367. Gabriel HM, Heger M, Innerhofer P, Zehetgruber M, Mundigler G, Wimmer M, Maurer
G, Baumgartner H. Long-term outcome of patients with ventricular septal defect considered
not to require surgical closure during childhood. J Am Coll Cardiol 2002;39:1066-1071.
368. Warnes С A, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido
P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford
MJ, Walsh EP, Webb GD, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM,
Buller CE, Creager MA, Ettinger SM, Halperin JL, Krumholz HM, Kushner FG, Lytle BW,
Nishimura RA, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2008 guidelines
for the management of adults with congenital heart disease: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to
Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in
Collaboration With the American Society of Echocardiography, Heart Rhythm Society,
International Society for Adult Congenital Heart Disease, Society for Cardiovascular
Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:el-
el21.
369. Moons P, De Voider E, Budts W, De Geest S, El en J, Waeytens K, Gewillig M. What
do adult patients with congenital heart disease know about their disease, treatment, and
prevention of complications? A call for structured patient education. Heart 2001 ;86:74-80.
370. Gersony WM, Hayes CJ, Driscoll DJ, Keane JF, Kidd L, O'Fallon WM, Pieroni DR,
Wolfe RR, Weidman WH. Bacterial endocarditis in patients with aortic stenosis, pulmonary
stenosis, or ventricular septal defect. Circulation 1993;87:I121 -1126.
371. Thilen U, Astrom-Olsson K. Does the risk of infective endarteritis justify routine patent
ductus arteriosus closure? Eur Heart J 1997;18:503-506.
372. Selton-Suty C, Hoen B, Grentzinger A, Houplon P, Maignan M, Juilliere Y,
Danchin N, Canton P, Cherrier F. Clinical and bacteriological characteristics of infective
endocarditis in the elderly. Heart 1997;77:260-263.
373. lung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW,
Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective
survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart
Disease. Eur Heart J2003;24:1231-1243.
374. Terpenning MS, Buggy BP, Kauffman CA. Infective endocarditis: clinical features in
young and elderly patients. Am J Med 1987;83:626-634.
375. Werner GS, Schulz R, Fuchs JB, Andreas S, Prange H, Ruschewski W, Kreuzer H.
Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical
features and prognosis compared with younger patients. Am J Med 1996;100:90-97.
376. Hoen B, Chirouze C, Cabell CH, Selton-Suty C, Duchene F, Olaison L, Miro JM, Habib
G, Abrutyn E, Eykyn S, Bernard Y, Marco F, Corey GR. Emergence of endocarditis due to group D
streptococci: findings derived from the merged database of the International Collaboration on
Endocarditis. Eur J Clin Microbiol Infect Dis 2005;24:12-16.
377. McDonald JR, Olaison L, Anderson DJ, Hoen B, Miro JM, Eykyn S, Abrutyn E, Fowler
VG Jr, Habib G, Selton-Suty C, Pappas PA, Cabell CH, Corey GR, Marco F, Sexton DJ.
Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged
database. Am J Med 2005; 118:759-766.
378. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell
CH, Ramos AI, Fowler V Jr, Hoen B, Konecny P, Moreno A, Murdoch D, Pappas P,
Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R. Current features of
infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis
Prospective Cohort Study. Arch Intern Med 2008;168:2095-2103.
379. Zamorano J, Sanz J, Moreno R, Almeria C, Rodrigo JL, de Marco E, Serra V, Samedi
M, Sanchez-Harguindey L. Better prognosis of elderly patients with infecious endocarditis in the
era of routine echocardiography and nonrestrictive indications for valve surgery. J Am Soc
88
Echocardiogr 2002; 15:702-707.
380. Foley MR. Cardiac disease. In: Dildy GA, Belfort MA, Saade GR, Phelan JP,
Hankins GDV, Clark SLeds. Critical care obstetrics. 4th ed. Maiden, MA: Blackwell Science; 2004.
p252-274.
381. Montoya ME, Karnath BM, Ahmad M. Endocarditis during pregnancy. South Med J
2003;96:1156-1157.
382. Dajani AS Jr., Taubert KA, Wilson W, Bolger AF, Bayer A, Ferried P, Gewitz MH,
Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter
G, Zuccaro G Jr. Prevention of bacterial endocarditis. Recommendations by the American Heart
Association. JAMA 1997;277:1794-1801.
383. Raoult D, Fournier PE, Vandenesch F, Mainardi JL, Eykyn SJ, Nash J, James E, Benoit-
Lemercier C, Marrie TJ. Outcome and treatment of Bartonella endocarditis. Arch Intern Med
2003; 163:226-230.
384. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations
for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother
2004;48:1921-1933.
385. Ghigo E, Capo C, Aurouze M, Tung CH, Gorvel JP, Raoult D, Mege JL. Survival of
Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. Infect
Immun2002;70:1501-1506.
386. Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in
MRC5 cells. Antimicrob Agents Chemother 2004;48:747-752.
89
Дата добавления: 2019-02-12; просмотров: 148; Мы поможем в написании вашей работы! |
Мы поможем в написании ваших работ!